Oncodesign Precision Medicine (XPAR:ALOPM) Total Payout Ratio : 0.00 (As of Apr. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Oncodesign Precision Medicine's current Total Payout Ratio is 0.00.

Oncodesign Precision Medicine Total Payout Ratio Historical Data

The historical data trend for Oncodesign Precision Medicine's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Total Payout Ratio Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Total Payout Ratio

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22
Total Payout Ratio	-	-	-

Competitive Comparison of Oncodesign Precision Medicine's Total Payout Ratio

For the Biotechnology subindustry, Oncodesign Precision Medicine's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Total Payout Ratio falls into.

Oncodesign Precision Medicine Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Oncodesign Precision Medicine's Total Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-2.944
	=	0.00

Oncodesign Precision Medicine's Total Payout Ratio for the quarter that ended in Jun. 2022 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-3.256
	=	0.00

Oncodesign Precision Medicine Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines